Jenna Davidner
Stock Analyst at Barclays
(2.34)
# 3,142
Out of 4,835 analysts
26
Total ratings
52.6%
Success rate
3.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jenna Davidner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings | Reiterated: Buy | $9 → $12 | $7.45 | +61.07% | 4 | Aug 20, 2026 | |
| COLL Collegium Pharmaceutical | Reiterated: Buy | $56 → $48 | $22.75 | +110.99% | 7 | Aug 18, 2026 | |
| PCRX Pacira BioSciences | Reiterated: Hold | $25 | $25.22 | -0.85% | 5 | Aug 17, 2026 | |
| PHAT Phathom Pharmaceuticals | Reiterated: Buy | $18 → $14 | $8.36 | +67.46% | 4 | Aug 17, 2026 | |
| TARS Tarsus Pharmaceuticals | Reiterated: Buy | $100 | $80.71 | +23.90% | 6 | Jul 10, 2026 |
Xeris Biopharma Holdings
Aug 20, 2026
Reiterated: Buy
Price Target: $9 → $12
Current: $7.45
Upside: +61.07%
Collegium Pharmaceutical
Aug 18, 2026
Reiterated: Buy
Price Target: $56 → $48
Current: $22.75
Upside: +110.99%
Pacira BioSciences
Aug 17, 2026
Reiterated: Hold
Price Target: $25
Current: $25.22
Upside: -0.85%
Phathom Pharmaceuticals
Aug 17, 2026
Reiterated: Buy
Price Target: $18 → $14
Current: $8.36
Upside: +67.46%
Tarsus Pharmaceuticals
Jul 10, 2026
Reiterated: Buy
Price Target: $100
Current: $80.71
Upside: +23.90%